We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Leslie built a successful career over 45+ years in senior management roles in both the pharmaceutical and medical device industries, culminating in the successful turnaround of a pharmaceutical business.
He was elected EMIG Chairman in 2005 and has been instrumental in the metamorphosis of EMIG from being a business/networking group to the influential trade association it is today. In 2005, EMIG began with 17 Member Companies and has 300+ today, of which, 90% choose to be represented only by EMIG. Consequently, EMIG represents c. 50% of UK branded medicines.
In July 2014, Leslie was elected VP, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and appointed to the Board of the EU Medical Cannabis Association in 2019. He was Vice Chairman of the NICE Project Development Group for Local Formularies Good Practice Guidance, a member of the NICE Medicines Optimisation Guidance Development Group and is currently an Expert Adviser to the NICE Centre for Clinical Practice.
He was involved with the negotiation of the 2019 Voluntary Scheme and is a Member of the Working Group for the NICE Review of Methods and Process. He has published numerous articles, is a frequent speaker at national and international seminars, a Member of MENSA and is a visiting lecturer at the University of Cambridge.
In April 2020, Leslie became co-founder and Chairman of Tetris Pharma Ltd.
Attending Masterclasses
Mon 24th Mar 2025 13:00 – 14:00 GMT
Mon 31st Mar 2025 13:00 – 14:00 GMT
Previous Masterclasses
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now